Healthcare provider profile · identity verified

Robert Pence, MD

Family Practice · DAYTON, VA · NPI 1801862131

Profile state: partd only Open Payments: 2025 Medicare Part D: 2024 Last identity check: 2026-08-10 Page data build: 2026-08-12

Verified facts

What the public records show

We did not find matching Open Payments records for this doctor in 2025.

These records do not establish that a payment influenced prescribing or medical care.

Payment overview · 2025

General Payments

We did not find matching Open Payments records for this doctor in the selected program year.

Separate record types

Research & Ownership

Research Payments (direct recipient): not present in the loaded data

Associated Research Funding (for example, named PI): not present in the loaded data

Ownership / Investment: not present in the loaded data

These categories are never added into the General Payments headline. Associated research funding must not be described as money the doctor personally received unless the source record supports that conclusion.

Analysis 1 · Payment-linked products

Products named in Open Payments records

No payment-linked product analysis is available because no matching General Payment records were found for the selected year.

Public prescribing for products named in payments

There is no explicit payment-product set available for a Part D comparison.

The presence of the same drug in both datasets does not show that a payment caused or influenced a prescription.

Analysis 2 · Same-company prescribing overlap

Drugs reported in other payments from the same company that also appear in Medicare Part D

This analysis is independent from products named on this doctor’s individual payment records. A row appears only when the exact Open Payments reporting entity paid this doctor, that same reporting entity reported the drug or biological on at least 10 loaded General Payment records involving at least 2 distinct recipient NPIs, and this doctor has the same non-generic brand in public Part D data. This does not mean the company owns or manufactures the drug.

There is no payer-company set available for this comparison.

These facts do not show that a payment was for the drug, that the company owns or manufactures the drug, or that a payment caused or influenced prescribing.

Public Medicare Part D data

Provider-and-drug rows loaded for 2024

Brand	Generic	Claims	Beneficiaries
Amlodipine Besylate	Amlodipine Besylate	959	226
Losartan Potassium	Losartan Potassium	926	227
Atorvastatin Calcium	Atorvastatin Calcium	794	216
Lisinopril	Lisinopril	499	128
Hydrochlorothiazide	Hydrochlorothiazide	475	128
Levothyroxine Sodium	Levothyroxine Sodium	460	116
Tamsulosin Hcl	Tamsulosin Hcl	343	97
Metoprolol Succinate	Metoprolol Succinate	340	92
Simvastatin	Simvastatin	336	87
Omeprazole	Omeprazole	332	99
Furosemide	Furosemide	321	102
Metformin Hcl	Metformin Hcl	319	82
Pravastatin Sodium	Pravastatin Sodium	319	78
Sertraline Hcl	Sertraline Hcl	318	73
Carvedilol	Carvedilol	302	71
Eliquis	Apixaban	277	60
Trazodone Hcl	Trazodone Hcl	274	69
Rosuvastatin Calcium	Rosuvastatin Calcium	271	75
Losartan-Hydrochlorothiazide	Losartan/Hydrochlorothiazide	258	68
Lisinopril-Hydrochlorothiazide	Lisinopril/Hydrochlorothiazide	221	59
Metoprolol Tartrate	Metoprolol Tartrate	202	58
Montelukast Sodium	Montelukast Sodium	202	54
Gabapentin	Gabapentin	185	52
Metformin Hcl Er	Metformin Hcl	185	57
Potassium Chloride	Potassium Chloride	167	41
Glipizide Er	Glipizide	161	40
Pantoprazole Sodium	Pantoprazole Sodium	157	43
Allopurinol	Allopurinol	155	40
Tramadol Hcl	Tramadol Hcl	139	54
Mirtazapine	Mirtazapine	138	38
Duloxetine Hcl	Duloxetine Hcl	136	29
Escitalopram Oxalate	Escitalopram Oxalate	136	36
Prednisone	Prednisone	129	64
Atenolol	Atenolol	121	30
Buspirone Hcl	Buspirone Hcl	120	23
Rybelsus	Semaglutide	109	20
Meloxicam	Meloxicam	106	26
Finasteride	Finasteride	105	30
Ezetimibe	Ezetimibe	104	26
Albuterol Sulfate Hfa	Albuterol Sulfate	99	45
Glipizide	Glipizide	97	27
Zolpidem Tartrate	Zolpidem Tartrate	94	17
Spironolactone	Spironolactone	92	30
Azithromycin	Azithromycin	90	81
Alendronate Sodium	Alendronate Sodium	85	20
Clopidogrel	Clopidogrel Bisulfate	85	24
Ozempic	Semaglutide	85	15
Doxazosin Mesylate	Doxazosin Mesylate	82	20
Warfarin Sodium	Warfarin Sodium	74	19
Donepezil Hcl	Donepezil Hcl	71	20
Fenofibrate	Fenofibrate Nanocrystallized	70	21
Lantus Solostar	Insulin Glargine,hum.Rec.Anlog	69	19
Fluticasone Propionate	Fluticasone Propionate	67	24
Synthroid	Levothyroxine Sodium	67	21
Amitriptyline Hcl	Amitriptyline Hcl	66	15
Esomeprazole Magnesium	Esomeprazole Magnesium	66	17
Ropinirole Hcl	Ropinirole Hcl	62	15
Terazosin Hcl	Terazosin Hcl	62	15
Tizanidine Hcl	Tizanidine Hcl	60	32
Olmesartan Medoxomil	Olmesartan Medoxomil	57	16
Bisoprolol-Hydrochlorothiazide	Bisoprolol/Hydrochlorothiazide	56	13
Famotidine	Famotidine	56	16
Doxycycline Hyclate	Doxycycline Hyclate	55	45
Nystatin	Nystatin	55	19
Pioglitazone Hcl	Pioglitazone Hcl	53	15
Benazepril Hcl	Benazepril Hcl	50	12
Trulicity	Dulaglutide	48	suppressed
Alprazolam	Alprazolam	47	18
Vitamin D2	Ergocalciferol (Vitamin D2)	47	14
Fluoxetine Hcl	Fluoxetine Hcl	45	11
Hydroxyzine Pamoate	Hydroxyzine Pamoate	44	15
Triamterene-Hydrochlorothiazid	Triamterene/Hydrochlorothiazid	44	suppressed
Chlorthalidone	Chlorthalidone	43	15
Jardiance	Empagliflozin	42	13
Bupropion Xl	Bupropion Hcl	41	suppressed
Quetiapine Fumarate	Quetiapine Fumarate	41	11
Oxybutynin Chloride Er	Oxybutynin Chloride	40	suppressed
Diazepam	Diazepam	38	suppressed
Ipratropium Bromide	Ipratropium Bromide	38	19
Xarelto	Rivaroxaban	38	suppressed
Nitrofurantoin Mono-Macro	Nitrofurantoin Monohyd/M-Cryst	36	25
Fluticasone-Salmeterol	Fluticasone Propion/Salmeterol	35	suppressed
Klor-Con M10	Potassium Chloride	35	12
Oxybutynin Chloride	Oxybutynin Chloride	35	suppressed
Cefuroxime	Cefuroxime Axetil	34	23
Lovastatin	Lovastatin	31	suppressed
Paroxetine Hcl	Paroxetine Hcl	31	suppressed
Glimepiride	Glimepiride	30	suppressed
Symbicort	Budesonide/Formoterol Fumarate	30	suppressed
Fluconazole	Fluconazole	29	13
Klor-Con M20	Potassium Chloride	29	suppressed
Breo Ellipta	Fluticasone/Vilanterol	28	suppressed
Clonazepam	Clonazepam	28	suppressed
Diclofenac Sodium	Diclofenac Sodium	28	suppressed
Ezetimibe-Simvastatin	Ezetimibe/Simvastatin	28	suppressed
Citalopram Hbr	Citalopram Hydrobromide	27	suppressed
Isosorbide Mononitrate Er	Isosorbide Mononitrate	26	suppressed
Cephalexin	Cephalexin	25	18
Clindamycin Phosphate	Clindamycin Phosphate	25	11
Clorazepate Dipotassium	Clorazepate Dipotassium	24	suppressed
Nebivolol Hcl	Nebivolol Hcl	24	suppressed
Amoxicillin-Clavulanate Potass	Amoxicillin/Potassium Clav	23	17
Bisoprolol Fumarate	Bisoprolol Fumarate	23	suppressed
Ondansetron Odt	Ondansetron	23	suppressed
Clonidine Hcl	Clonidine Hcl	22	suppressed
Ciclopirox	Ciclopirox	21	suppressed
Ciprofloxacin Hcl	Ciprofloxacin Hcl	21	12
Hydrocodone-Acetaminophen	Hydrocodone/Acetaminophen	21	suppressed
Oxycodone-Acetaminophen	Oxycodone Hcl/Acetaminophen	21	suppressed
Triamcinolone Acetonide	Triamcinolone Acetonide	21	14
Levofloxacin	Levofloxacin	20	20
Lorazepam	Lorazepam	20	suppressed
Dicyclomine Hcl	Dicyclomine Hcl	19	suppressed
Irbesartan	Irbesartan	19	suppressed
Farxiga	Dapagliflozin Propanediol	18	suppressed
Memantine Hcl	Memantine Hcl	18	suppressed
Metoclopramide Hcl	Metoclopramide Hcl	18	suppressed
Ondansetron Hcl	Ondansetron Hcl	18	suppressed
Colchicine	Colchicine	17	suppressed
Gemfibrozil	Gemfibrozil	17	suppressed
Pregabalin	Pregabalin	17	suppressed
Benazepril-Hydrochlorothiazide	Benazepril/Hydrochlorothiazide	16	suppressed
Bumetanide	Bumetanide	16	suppressed
Janumet	Sitagliptin Phos/Metformin Hcl	16	suppressed
Lansoprazole	Lansoprazole	16	suppressed
Midodrine Hcl	Midodrine Hcl	16	suppressed
Verapamil Er	Verapamil Hcl	16	suppressed
Budesonide-Formoterol Fumarate	Budesonide/Formoterol Fumarate	15	suppressed
Creon	Lipase/Protease/Amylase	15	suppressed
Cyclobenzaprine Hcl	Cyclobenzaprine Hcl	15	suppressed
Nano 2nd Gen Pen Needle	Pen Needle, Diabetic	15	suppressed
Ramipril	Ramipril	15	suppressed
Ultra-Fine Mini Pen Needle	Pen Needle, Diabetic	15	suppressed
Azelastine Hcl	Azelastine Hcl	14	suppressed
Basaglar Kwikpen U-100	Insulin Glargine,hum.Rec.Anlog	14	suppressed
Januvia	Sitagliptin Phosphate	14	suppressed
Meclizine Hcl	Meclizine Hcl	14	suppressed
Nitroglycerin	Nitroglycerin	14	12
Raloxifene Hcl	Raloxifene Hcl	14	suppressed
Dextroamphetamine-Amphetamine	Dextroamphetamine/Amphetamine	13	suppressed
Fenofibrate	Fenofibrate,micronized	13	suppressed
Lamotrigine	Lamotrigine	13	suppressed
Nifedipine Er	Nifedipine	13	suppressed
Ventolin Hfa	Albuterol Sulfate	13	suppressed
Amoxicillin	Amoxicillin	12	11
Anoro Ellipta	Umeclidinium Brm/Vilanterol Tr	12	suppressed
Diclofenac Sodium Er	Diclofenac Sodium	12	suppressed
Dilantin	Phenytoin Sodium Extended	12	suppressed
Epinephrine	Epinephrine	12	suppressed
Levetiracetam	Levetiracetam	12	suppressed
Myrbetriq	Mirabegron	12	suppressed
Prazosin Hcl	Prazosin Hcl	12	suppressed
Risperidone	Risperidone	12	suppressed
Temazepam	Temazepam	12	suppressed
Topiramate	Topiramate	12	suppressed
Trelegy Ellipta	Fluticasone/Umeclidin/Vilanter	12	suppressed
Tresiba Flextouch U-100	Insulin Degludec	12	suppressed
Acyclovir	Acyclovir	11	suppressed
Atenolol-Chlorthalidone	Atenolol/Chlorthalidone	11	suppressed
Bupropion Hcl Sr	Bupropion Hcl	11	suppressed
Carbidopa-Levodopa Er	Carbidopa/Levodopa	11	suppressed
Celecoxib	Celecoxib	11	suppressed
Fenofibrate	Fenofibrate	11	suppressed
Hydroxychloroquine Sulfate	Hydroxychloroquine Sulfate	11	suppressed
Testosterone	Testosterone	11	suppressed
Zolpidem Tartrate Er	Zolpidem Tartrate	11	suppressed

Timeline

Payment and prescribing data by year

Open Payments and Medicare Part D may refer to different years. They are shown separately rather than aligned as if they describe the same period.

Year	General Payments	Main payer	Explicit products	Company overlaps	Part D coverage
2025	—	—	—	—	—
2024	—	—	—	—	Complete

Questions to ask

Questions you could discuss with your doctor

Are there reasonable alternatives I should understand when we discuss treatment options?
How should I interpret the industry-payment records shown here in the context of my care?

These are general questions generated from reviewed templates. They are not personalized medical advice.

Sources and limitations

How to read this page

Payment and Medicare prescribing data can cover different years; every comparison shows both years explicitly.
Part D does not represent a doctor’s entire practice; it excludes many patients and is subject to CMS public-release thresholds.
Company–drug relationships must have an auditable source, a precise relationship type, and a valid evidence period. Unresolved mappings are not published.
Generic drug claims are not attributed to a specific manufacturer without manufacturer-level evidence.
When a source extract is incomplete, missing rows are never treated as proof of no payments or no prescriptions.

Loaded source releases

Dataset	Year	Publication	Source
CMS Open Payments — General Payments	2025	2026-06-30	Original source
Medicare Part D Prescribers by Provider and Drug	2024	2026-05-06	Original source
NPPES Data Dissemination V2	current / reference data	2026-08-10	Original source

Methodology version: 2.1

Editorial template version: 2.4

Product contract version: 2.0

Schema version: 0.7.0

Page data build: 2026-08-12T23:34:59.370714+00:00

Publication policy: eligible for indexing after public-launch controls are enabled

Full methodology · Questions & answers · Report a possible error